Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations.
Tiede A, Tait RC, Shaffer DW, Baudo F, Boneu B, Dempfle CE, Horellou MH, Klamroth R, Lazarchick J, Mumford AD, Schulman S, Shiach C, Bonfiglio LJ, Frieling JT, Conard J, von Depka M.
Tiede A, et al. Among authors: mumford ad.
Thromb Haemost. 2008 Mar;99(3):616-22. doi: 10.1160/TH07-08-0489.
Thromb Haemost. 2008.
PMID: 18327412
Clinical Trial.